460 likes | 1.74k Views
OBJECTIVES. Intra-dialysis complications.Post-dialysis complications.Management of complications.Preventions.. . The incidence of ESRD is likely to be higher than that reported from the developed worldreported annual incidence from developing countries varies from 34 to 240 per million popula
E N D
2. COMPLICATIONS OF DIALYSIS
Dr
3. OBJECTIVES Intra-dialysis complications.
Post-dialysis complications.
Management of complications.
Preventions.
4.
The incidence of ESRD is likely to be higher than that reported from the developed world
reported annual incidence from developing countries varies from 34 to 240 per million population which is in contrast to an incidence between 98 and 198 pmp per year reported from ESRD registries maintained in the developed countries
less than 10% of all patients receive any kind of renal replacement therapy
7. INTRA-DIALYSIS COMPLICATION Hypoxemia --- 90% (5-30% sat. falls)
Hypotension — 25 to 55 percent of treatments
Cramps — 5 to 20 percent
Nausea and vomiting — 5 to 15 percent
Headache — 5 percent
Chest pain — 2 to 5 percent
Back pain — 2 to 5 percent
Itching — 5 percent
Fever and chills — Less than 1 percent
8. POST-DIALYSIS COMPLICATIONS Infection.
Disequilibrium syndrome.
Malnutrition.
Hemorrhage.
Gastrointestinal Effects.
Psychiatric Illness (Depression).
9.
INTRA DIALYSIS
COMPLICATIONS
10. HYPOTENSION Hypotension.
Excessive ultra filtration with inadequate vascular refilling
Impaired vasoactive or autonomic responses
Osmolar shifts
Overuse of anti HTNsive drugs
Reduced cardiac response
Acetate buffer(HCO3)
Treat Hypotension.
immediately discontinue dialysis and place the patient in a trendelenburg position
Infusion of Saline (isotonic/hypertonic)
11. HEADACHE, NAUSEA VOMITING Hypotension.
Longer treatment times.
Ultra filtration in association with a large degree of solute removal.
Other Causes…
Metabolic disturbances (hypoglycemia, hypernatremia, and hyponatremia)
Uremia.
Subdural hematoma.
Medication-induced headaches.
12. CRAMPS Occur toward the end of the dialysis procedure.
Because of
Significant fluid volume removal by ultra filtration
Use of low Na containing dialysate
Immediate treatment
restoring intravascular volume through the use of small boluses of isotonic saline
Prevention
Reduced volume removal during dialysis
Use of hi conc. of Na in dialysate
Has been attempted with the prophylactic use of quinine sulfate at least 2 hours prior to dialysis
13. CHEST PAIN Associated with
Hypotension or
dialysis disequilibrium syndrome.
Additional possibilities should always be considered
angina
hemolysis
rarely air embolism
14. Decision to continue or stop the dialysis treatment because of chest pain is based upon clinical findings, such as
Hemodynamic stability,
The history
Physical examination
15. Angina History, physical examination, electrocardiogram and cardiac enzyme evaluation should be performed.
If dialysis is continued
administration of oxygen and aspirin
reduction of the desired ultra filtration
administration of nitrates or morphine should be considered.
Prevented with the administration of nitrates and/or beta blockers.(hypotension)
16. Hemolysis Findings suggestive of hemolysis
C/O chest pain, shortness of breath or back pain
Port wine appearance of the blood in the venous line
Pink color of the plasma in centrifuged specimens
Cause
Overheating
Hypotonicity
Kinking of dialysis tubing.
Biochemical/toxin insult
Decreased life span
Management
stop dialysis immediately
clamp the blood lines (do not return the blood, K )
prepare to treat hyperkalemia and the potentially severe anemia
17. AIR EMBOLISM Rare
Symptoms
Neurological
Cardiovascular
Treatment
Clamping the venous line and stopping the blood pump.
Cardio respiratory support.
Left sided supine position with the chest and head tilted downward.
Prevention
Adequate function of monitoring devices on dialysis machine
18. ARRHYTHMIAS In pts. on maintenance dialysis
Ventricular, SVT arrhythmias
Risk Factors
coronary artery disease, advanced age, myocardial dysfunction, and left ventricular hypertrophy
Incidence of arrhythmias enhanced because of rapid fluctuations in fluid, electrolyte and pH, induction of hypoxemia.
Treatment same as non-dialysis person, with appropriate dosing according to renal status.
19. Hypoxemia A fall in arterial PO2 is a frequent complication of hemodialysis that occurs in nearly 90% of patients.
The drop ranges from 5 to 35 saturation, and reaches its peak between 30 - 60 minutes after beginning dialysis.
Increase risk for patients with underlying cardiopulmonary disease.
Oxygen Inhalation.
20.
POST DIALYSIS
COMPLICATIONS
21. INFECTIONS Infections are common d/t:
inadequate dialysis
Malnutrition
frequent use of blood transfusions to correct anemia
Impaired host immunity
Peritonitis
Vascular access
Bacteremia
Sepsis
Generally immunocompromised, more risk of developing UTI, Fungal infections etc
Use of Topical Antimicrobials
Mupirocin, Povidone-iodine
Triple agents - bacitracin, gramicidin, and polymyxin B
22. Disequilibrium syndrome Neurologic symptoms of varying severity
headache, nausea
disorientation, restlessness
blurred vision, and asterixis
confusion, seizures, coma, and even death
Cause: Cerebral edema due to,
a reverse osmotic shift induced by urea removal
fall in cerebral intracellular pH
Treatment
by raising the plasma osmolality with either 5 mL of 23 percent saline or 12.5 g of hypertonic mannitol
23. Prevention (in high-risk patients)
Prophylactic use of phenytoin
hypertonic mannitol
High Risk Patients:
New patients, particularly if the BUN is markedly elevated ( > 175 mg/dL)
severe metabolic acidosis
older age
presence of other central nervous system disease i.e. seizures.
24. Hemorrhage Peptic Ulcer
Hemorrhagic Esophagitus
Angiodysplasia
Haemorrhagic Pericarditis (3-5% of Dialysis pt)
Sub Dural Haematoma
Spontaneous retroperitoneal bleeding (Rare)
25. GIT EFFECTS Dyspepsia
Peptic Ulcer Disease (PUD)
UGIB (PUD/Angiodysplasia)
Gastroparesis
Idiopathic Dialysis Ascities
Straw-colored appearance
High protein content (3 to 6 gm/dL) Leukocyte count -25 to 1600 cells/mm3
26. PSYCHIATRIC ILLNESS Account for a 1.5 to 3.0 times higher rate of hospitalization among dialysis patients compared to those with other chronic illnesses.
Affective disorders, particularly depression
Organic brain diseases (eg, dementia and delirium)
Schizophrenia and other psychoses
27. DEPRESSION Exclude uremia and assure adequate dialysis before diagnosing depression, since the symptoms of depression and those originating from a somatic process or disorder are similar:
Signs and symptoms of under-dialysis, including anorexia and failure to thrive, may mirror those of depression.
Correction of fluctuating blood pressure, nausea, or other gastrointestinal complaints may improve quality of life and lift spirits in chronically ill patients; thus, such therapy may effectively treat psychosocial markers suggesting depression.
Common complaints in the dialysis patient, such as chronic fatigue, weakness, and constipation, may reflect a psychosocial disturbance.
mental status exam is required to help distinguish an encephalopathy from depression
Antidepressants
28. FISTULA RELATED COMPLICATION Infections
Thrombus
Aneurysm
Vascular Steal syndrome
Venous Hypertension (Sore thumb Syndrome)
High cardiac output failure (shunting of blood)
31. MEDICATIONS S/E Erythropoietin
Hypertension
Encephalopathy with Seizure
Hyperkalemia
Skin irritation
Vascular access thrombosis
32. MALNUTRITENT A variety of causes have been implicated in the development of malnutrition
Malabsorption and gastrointestinal motility disorders
Impaired taste acuity
Anorexia
Chronic constipation
Depression
Several dialytic and hormonal-metabolic factors
Drugs Effect
33. Dialysis Related Amyloidosis The carpal tunnel syndrome is one of the most frequent presenting manifestations
DRA.
Average time to onset being approximately 8 to 10 years after the initiation of dialysis.
34. Mortality in dialysis pt annual mortality rate of dialysis patients is 20- 30%
Together, uremic complications and infections account for 57% of all deaths
ischemic heart disease…<30%
prevalence of hepatitis B and C virus infections varies between 4 to 12% and 4 to 16%, respectively